參考文獻(xiàn)
1. Cavia-Saiz M, Muniz Rodriguez P, Llorente Ayala B, Garcia-Gonzalez M, Coma-Del Corral MJ, Garcia Giron C. The role of plasma IDO activity as a diagnostic marker of patients with colorectal cancer. Mol Biol Rep. 2014 Apr; 41(4):2275-9.
2. Chuang SC, Fanidi A, Ueland PM et al: Circulating biomarkers of tryptophan and the kynurenine pathway and lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2014 Mar; 23(3):461-8 Manual IDKR Kynurenine high sensitive ELISA 29
3. Creelan BC, Antonia S, Bepler G, Garrett TJ, Simon GR, Soliman HH: Indoleamine 2,3-dioxygenase activity and clinical outcome following induction chemotherapy and concurrent chemoradiation in Stage III nonsmall cell lung cancer. Oncoimmunology. 2013 Mar 1; 2(3):e23428
4. Eussen S J PM, Ueland P M, Vollset S E, Nygard O, Midttun O, Sulo G,Tell GS: Kynurenines as predictors of acute coronary events in the Hordaland Health Study. Int J Cardiol. 2015 Jun 15;189:18-24
5. Gupta NK, Thaker AI, Kanuri N, Riehl TE, Rowley CW, Stenson WF, Ciorba MA: Serum analysis of tryptophan catabolism pathway: correlation with Crohn's disease activity. Inflamm Bowel Dis. 2012 Jul; 18(7):1214-20.
6. Murray C, Griffin EW, O’Loughlin E, Lyons A, Sherwin E, Ahmed S, Stevenson N J, et al. Interdependent and independent roles of type I interferons and IL-6 in innate immune, neuroinflammatory and sickness behaviour responses to systemic poly I:C. Brain, Behavior, and Immunity. 2015, 48: 274-286.
7. Pedersen ER, Svingen GF, Schartum-Hansen H, Ueland PM, Ebbing M, Nordrehaug JE, Igland J, Seifert R, Nilsen RM, Nygard O: Urinary excretion of kynurenine and tryptophan, cardiovascular events, and mortality after elective coronary angiography. Eur Heart J. 2013 Sep; 34(34):2689-96.
8. Ristagno G, Latini R, Vaahersalo J, Masson S, Kurola J, Varpula T, Lucchetti J, Fracasso C, Guiso G, Montanelli A, Barlera S, Gobbi M, Tiainen M, Pettila V, Skrifvars MB; FINNRESUSCI Investigators: Early activation of the kynurenine pathway predicts early death and long-term outcome in patients resuscitated from out-of-hospital cardiac arrest. J Am Heart Assoc. 2014; 3:e001094
9. Sulo G, Vollset SE, Nygard O, Midttun O, Ueland PM, Eussen SJ, Pedersen ER, Tell GS: Neopterin and kynurenine-tryptophan ratio as predictors of coronary events in older adults, the Hordaland Health Study. Int J Cardiol. 2013 Sep 30; 168(2):1435-40
10. Suzuki Y, Suda T, Asada K, Miwa S, Suzuki M, Fujie M, Furuhashi K, Nakamura Y, Inui N, Shirai T, Hayakawa H, Nakamura H, Chida K: Serum Indoleamine 2,3- Dioxygenase Activity Predicts Prognosis of Pulmonary Tuberculosis. Clin Vaccine Immunol. 2012 March; 19(3): 436–442
11. Yan EB, Frugier T, Lim CK, Heng B, Sundaram G, Tan M, Rosenfeld JV, et al. Activation of the kynurenine pathway and increased production of the excitotoxin quinolinic acid following traumatic brain injury in humans. Journal of Neuroinflammation. 2015,12(1), 110.
相關(guān)指標(biāo)推薦
1. 人抗酒石酸酸性磷酸酶5b試劑盒(TRACP 5b) 腎性骨營(yíng)養(yǎng)不良檢測(cè)指標(biāo)
2. 骨堿性磷酸酶檢測(cè)試劑盒(酶聯(lián)免疫法) 腎病患者骨形成檢測(cè)指標(biāo)
3. FGF23(C端)檢測(cè)試劑盒(酶聯(lián)免疫法) 磷穩(wěn)態(tài)的調(diào)節(jié)劑
4. 人全段甲狀旁腺激素檢測(cè)試劑盒(酶聯(lián)免疫法) 診斷鈣代謝紊亂的重要輔助工具(PTH維持鈣穩(wěn)態(tài))
5. 25-羥基維生素D檢測(cè)試劑盒(酶聯(lián)免疫法) 檢測(cè)體內(nèi)25(OH)D水平,有效預(yù)防維生素D不足或缺乏
6. 1,25雙羥基維生素D檢測(cè)試劑盒(酶聯(lián)免疫法) 維生素D的生物活性鑒定,適用于腎衰竭、腎移植術(shù)后檢測(cè)
7. C4D 腎移植后體液排斥反應(yīng)檢測(cè)指標(biāo)